Ilona Mirecki

492 total citations
12 papers, 392 citations indexed

About

Ilona Mirecki is a scholar working on Psychiatry and Mental health, Pharmacology and General Health Professions. According to data from OpenAlex, Ilona Mirecki has authored 12 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 2 papers in General Health Professions. Recurrent topics in Ilona Mirecki's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ilona Mirecki is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ilona Mirecki collaborates with scholars based in Israel and United States. Ilona Mirecki's co-authors include Yoram Barak, Dov Aizenberg, Anat Achiron, Doron Mazeh, Diana Paleacu, Michaël Even, Ronit Weizman, Eyal Shamir, Ehud Bodner and Paz Toren and has published in prestigious journals such as Cancer, Psychopharmacology and The Journal of Nervous and Mental Disease.

In The Last Decade

Ilona Mirecki

12 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilona Mirecki Israel 9 260 64 64 55 46 12 392
Doron Mazeh Israel 16 326 1.3× 89 1.4× 86 1.3× 35 0.6× 59 1.3× 21 544
Graeme Archer United Kingdom 9 183 0.7× 84 1.3× 69 1.1× 68 1.2× 23 0.5× 15 488
L.S. Volonteri Italy 10 304 1.2× 94 1.5× 85 1.3× 50 0.9× 21 0.5× 17 479
Neil M. Kurtz United States 11 189 0.7× 74 1.2× 50 0.8× 39 0.7× 26 0.6× 18 393
Adam Simmons United States 11 239 0.9× 93 1.5× 36 0.6× 45 0.8× 50 1.1× 30 353
Angela Hill United States 10 235 0.9× 50 0.8× 113 1.8× 20 0.4× 34 0.7× 21 422
R.N. Marcus United States 5 396 1.5× 71 1.1× 59 0.9× 24 0.4× 50 1.1× 10 449
Lara McCartney Australia 5 402 1.5× 48 0.8× 76 1.2× 31 0.6× 23 0.5× 5 495
Mark D. Watanabe United States 7 252 1.0× 60 0.9× 84 1.3× 50 0.9× 14 0.3× 11 414
L. Ford United States 8 247 0.9× 58 0.9× 26 0.4× 44 0.8× 26 0.6× 12 545

Countries citing papers authored by Ilona Mirecki

Since Specialization
Citations

This map shows the geographic impact of Ilona Mirecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Mirecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Mirecki more than expected).

Fields of papers citing papers by Ilona Mirecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilona Mirecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Mirecki. The network helps show where Ilona Mirecki may publish in the future.

Co-authorship network of co-authors of Ilona Mirecki

This figure shows the co-authorship network connecting the top 25 collaborators of Ilona Mirecki. A scholar is included among the top collaborators of Ilona Mirecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilona Mirecki. Ilona Mirecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Swartz, Marnina, et al.. (2016). Physicians’ Life Satisfaction in Bhutan: A Nationwide Survey. Open Journal of Psychiatry. 6(1). 119–124. 4 indexed citations
2.
Baruch, Yehuda, et al.. (2013). Staff happiness and work satisfaction in a tertiary psychiatric centre. Occupational Medicine. 63(6). 442–444. 15 indexed citations
3.
Mazeh, Doron, et al.. (2006). Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study. International Psychogeriatrics. 18(3). 429–436. 26 indexed citations
4.
Barak, Yoram, et al.. (2005). Reduced cancer incidence among patients with schizophrenia. Cancer. 104(12). 2817–2821. 134 indexed citations
5.
6.
Barak, Yoram, Eyal Shamir, Ilona Mirecki, Ronit Weizman, & Dov Aizenberg. (2004). Switching elderly chronic psychotic patients to olanzapine. The International Journal of Neuropsychopharmacology. 7(2). 165–169. 14 indexed citations
8.
Paleacu, Diana, Doron Mazeh, Ilona Mirecki, Michaël Even, & Yoram Barak. (2002). Donepezil for the Treatment of Behavioral Symptoms in Patients With Alzheimer's Disease. Clinical Neuropharmacology. 25(6). 313–317. 41 indexed citations
9.
Barak, Yoram, et al.. (2002). Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(6). 1199–1202. 31 indexed citations
10.
Barak, Yoram, Dov Aizenberg, Ilona Mirecki, Doron Mazeh, & Anat Achiron. (2002). VERY LATE-ONSET SCHIZOPHRENIA-LIKE PSYCHOSIS: CLINICAL AND IMAGING CHARACTERISTICS IN COMPARISON WITH ELDERLY PATIENTS WITH SCHIZOPHRENIA. The Journal of Nervous and Mental Disease. 190(11). 733–736. 46 indexed citations
11.
Barak, Yoram, et al.. (2001). Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: a 6-month open trial. Archives of Gerontology and Geriatrics. 33(3). 237–241. 24 indexed citations
12.
Swartz, Marnina, et al.. (2000). Treating Depression in Alzheimer's Disease:Integration of Differing Guidelines. International Psychogeriatrics. 12(3). 353–358. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026